Martin Lauss
- Molecular Biology top 5%
- Oncology top 2%
- Surgery top 2%
- Pulmonary and Respiratory Medicine top 5%
- Immunology top 5%
- Co-authors
- Mattias HöglundMarkus RingnérGunilla ChebilSigurður GuðjónssonWiking MånssonGottfrid SjödahlDavid LindgrenFredrik Liedberg
- Topics
- Cancer Immunotherapy and Biomarkers (12 papers)Bladder and Urothelial Cancer Treatments (10 papers)Melanoma and MAPK Pathways (10 papers)
- Cited by
- OncologyCancer ResearchImmunology
In The Last Decade
Martin Lauss
51 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Molecular Biology 1.5k
- Oncology 1.2k
- Surgery 1.2k
- Pulmonary and Respiratory Medicine 654
- Immunology 604
Countries citing papers authored by Martin Lauss
This map shows the geographic impact of Martin Lauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Lauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Lauss more than expected).
Fields of papers citing papers by Martin Lauss
This network shows the impact of papers produced by Martin Lauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Lauss. The network helps show where Martin Lauss may publish in the future.
Co-authorship network of co-authors of Martin Lauss
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Lauss. A scholar is included among the top collaborators of Martin Lauss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Lauss. Martin Lauss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 21 | |
| 5 | 86 | |
| 6 | 14 | |
| 7 | 68 | |
| 8 | 77 | |
| 9 | 51 | |
| 10 | 27 | |
| 11 | 23 | |
| 12 | 82 | |
| 13 | 99 | |
| 14 | 57 | |
| 15 | 72 | |
| 16 | A Molecular Taxonomy for Urothelial Carcinomabreakdown → | 637 |
| 17 | 96 | |
| 18 | 28 | |
| 19 | 23 | |
| 20 | 21 |
About Martin Lauss
Martin Lauss is a scholar working on Oncology, Cancer Research and Immunology, having authored 52 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Bladder and Urothelial Cancer Treatments (10 papers) and Melanoma and MAPK Pathways (10 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (543 citations) and Immunology (604 citations). Martin Lauss has collaborated with scholars based in Sweden, Denmark and Austria. Frequent co-authors include Mattias Höglund, Markus Ringnér, Gunilla Chebil, Sigurður Guðjónsson, Wiking Månsson, Gottfrid Sjödahl, David Lindgren, Fredrik Liedberg, Göran Jönsson and Kristina Lövgren. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.